ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) (“Aspire” or the “Company”), a developer of a multi-faceted patent-pending drug delivery technology, ...

Pharmaceutical giant Bristol Myers Squibb is currently offering a 4.7% yield. The dividend hasn't been increased every single ...

Across Ohio, researchers are achieving medical breakthroughs on what seems to be a monthly basis. Unfortunately, proposed legislation in Congress threatens to undermine Buckeye State scientists by ...

Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...

The Sedona Conference invites public comment by Jan. 17, 2026 on its recently published draft Model Jury Instructions for the ...

Ron DiCerbo of McAndrews, Held & Malloy, Ltd. discusses how brand owners can use Schedule A litigation to efficiently combat ...

The adoption of biosimilars is increasing, with a predicted global market CAGR of 18%, though uptake varies by market and is influenced by factors like rebate schemes and patent litigation.

CPTech secured patents in Saudi Arabia and the U.S. for its core pyrolysis oil upgrading process, part of its campaign to ...

The University of Delaware’s David Martin, Karl W. and Renate Böer Chair in the Department of Materials Science and Engineering, has been named to the National Academy of Inventors (NAI) 2025 Class of ...

Lastly, AbbVie is a fantastic income stock. The company is part of the group of Dividend Kings, corporations that have ...